MitraClip implantation significantly improved six-minute walk distance from 265 m to 295 m at four weeks in patients with secondary mitral regurgitation.
Cohort (n=79)
No
What are the baseline predictors of functional improvement (6MWD) after MitraClip implantation in high-risk patients with secondary mitral regurgitation?
The study aims to identify baseline predictors of short-term functional improvement (6MWD) after MitraClip in secondary MR to aid in patient selection.
Absolute Event Rate: 295% vs 265%
p-value: p=<0.001
MitraClip implantation is an established therapy for secondary mitral regurgitation (MR) in high-risk patients and has shown to improve several important outcome parameters such as functional capacity. Patient selection is both challenging and crucial for achieving therapeutic success. This study investigated baseline predictors of functional improvement as it was quantified by the six-minute walk distance (6MWD) after transcatheter mitral valve repair.
Paulus et al. (Thu,) conducted a cohort in Secondary mitral regurgitation (n=79). MitraClip implantation vs. Baseline was evaluated on Six-minute walk distance (6MWD) (p=<0.001). MitraClip implantation significantly improved six-minute walk distance from 265 m to 295 m at four weeks in patients with secondary mitral regurgitation.